Back to User profile » Dr Carmela Nappi
Papers published by Dr Carmela Nappi:
Epidemiology, patient profile, and health care resource use for hepatitis C in Italy
Sangiorgi D, Perrone V, Buda S, Boglione L, Cariti G, Lefevre C, Nappi C, Degli Esposti L
ClinicoEconomics and Outcomes Research 2017, 9:609-616
Published Date: 10 October 2017
Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial
Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D
ClinicoEconomics and Outcomes Research 2017, 9:569-571
Published Date: 27 September 2017
Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum]
Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D
ClinicoEconomics and Outcomes Research 2017, 9:231-232
Published Date: 19 April 2017
Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial
Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D
ClinicoEconomics and Outcomes Research 2017, 9:173-179
Published Date: 1 March 2017
Drug usage analysis and health care resources consumption in naïve patients with rheumatoid arthritis
Sangiorgi D, Benucci M, Nappi C, Perrone V, Buda S, Degli Esposti L
Biologics: Targets and Therapy 2015, 9:119-127
Published Date: 6 November 2015